Urine Drugs of Abuse

Urine Drugs of Abuse

The demand for Drugs of Abuse testing has risen rapidly over the years, especially in a Point of Care Setting due to a variety of Medical, Professional and Legal reasons. Weqas provides an ISO 17043 accredited Urine Drugs of Abuse programme suitable for Laboratory and Point of Care testing sites.

The programme will provide liquid stable samples that are commutable, stable and fit for intended purpose. We also provide education and training to understand the importance of evidence based quality assurance for minimising pre-analytical errors and reporting of erroneous test results.

Three liquid stable commutable samples are distributed bimonthly. The material is prepared from sterile urine from healthy donors, 3.0 mL volume supplied in sterile plastic tubes.

Frequency: Bimonthly

Samples per set: 3 x 3.0 mL samples

Urine Drugs of Abuse Programme
AnalyteApprox. Range Covered
Amphetamine0 - 3000µg/L
Benzodiazepine0 - 1000µg/L
Barbiturate0 - 1000µg/L
Buprenorphine0 - 50µg/L
Cocaine0 - 1000µg/L
Cannabis0 - 150µg/L
Heroin0 - 50µg/L
Ketamine0 - 3000µg/L
Methadone0 - 1000µg/L
EDDP0 - 1000µg/L
Methamphetamine (mAMP)0 - 3000µg/L
Opiate0 - 3000µg/L
Phencyclidine (PCP)0 - 100µg/L
Tricyclic antidepressants (TCA)0 - 3000µg/L
MDMA0 - 3000µg/L
Amphetamines Group ScreenQualitative n/a

Related Documents

 

Browse all Laboratory EQA Programmes

Accreditation

UKAS Proficiency Testing 4301UKAS Calibration 4301


Events